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FOLATE DEFICIENCY ALTERS HOMOCYSTEINE CYCLE 
IN THE COCHLEA AND CAUSES PREMATURE HEARING 
LOSS IN MICE 
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FOLATE DEFICIENT MICE SHOW EARLY SIGNS OF SEVERE 
SENSORINEURAL HEARING LOSS:  
Increased hearing thresholds and altered latencies 
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MATERIAL & METHODS 
Cochlear morphology from NF (A-H) and FD (I–P) mice. Basal (A-D, I-L) and middle (E-H, M-P) turn details of the organ of Corti 
(A, B, E, F, I, J, M, N), cochlear ganglion (C, C´, G, G´, K, K´, O, O´) and stria vascularis (D, D´, H, H´, L, L´, P, P´). Phalloidin (Phal) 
immunolabelling of the organ of Corti  (B, F, J, N). Detail of the cochlear ganglion neurons (C´, G´, K´, O´) labelled with myelin P0 
(P0). Detail of the stria vascularis (D´, H´, M´, P´) immunolabelled with Kir4.1 (Kir4.1). Arrows (J, K) and stars (I) show the absence 
of cells. Q, R, S. Quantitative analyses of the intensity of the expression of myelin P0 (P), Kir4.1 (S) and of the relative intensity of 
neuronal loss/cochlear ganglion. Scale bars: 10 µm (C´, G´, K´, O´); 50 µm (B, F, J, N) and 100 µm for the rest.  
Animals: 8 week-old female C75BL/6J mice (Harlan ™) were divided in two groups receiving Normal folate  (NF; Mouse 
Breeder Diet) or Folate deficient (FD; TD.95247) diets for an additional eight-week period.  
Plasmatic metabolite levels: Folate and pHcy levels were determined using an IMx System (Abbot Laboratories). B6 
levels were obtained by HPLC, essentially as described (5). 
Hearing assessment:  ABR evaluation was performed in a sound-attenuating chamber by using click and tone burst 
stimulus generated using TDT equipment (Tucker Davis Technologies), as described (6). One-way analysis of variance 
(with Bonferroni post hoc test) was performed using PASW 21 statistics software.  
Cochlear morphology: Inner ear samples were frozen or prepared for paraffin inclusion. Sections were made following 
standard procedures (7, 8) and used for hematoxylin-eosin staining. Paraffin sections were used for 3-Nitrotyrosine (3-
NT) and Myelin protein zero immunohistochemistries, whereas frozen tissues were preferred for potassium channel 
Kir4.1 and phalloidin immunolabelling.  ImageJ was used for quantifying immunohistochemistry intensity staining.  
Western blot and real-time PCR: Whole cochlear protein and total mRNA were prepared as previously reported (9) and 
used for western blot and RT-qPCR determinations.  
 
The methionine/homocysteine (Hcy) cycle is modulated by nutritional factors and its 
alterations have been associated to several pathologies including deafness (1).  A recent 
study, conducted in humans, showed that folic acid supplementation slowed down the 
loss of hearing speech frequencies associated with aging (2). Increased pHcy levels 
could result from a decreased flux through the trans-sulfuration pathway leading to a 
reduced production of glutathione. Such an effect, together with an increase in the 
atherogenic and neurotoxic effects of Hcy, constitute a risk factor for the function of 
the cochlear structure and, as a consequence, hearing function may be compromised. 
Here, we have studied the impact of a dietary-induced folic acid deficiency on cochlear 
Hcy metabolism and in hearing using C57Bl/6J mice, a well-known model of 
progressive hearing loss due to the Ahl alleles present in its genome (3, 4).  
INTRODUCTION 
1. Folic acid deficiency causes systemic hyperhomocysteinemia and global alteration in the levels of cochlear Hcy 
metabolism enzymes, concomitant with cochlear oxidative imbalance. 
2. These alterations in the methionine cycle secondary to folic acid deficit caused a premature onset of sensorineural 
hearing loss and cochlear cellular alterations.  
3. Altogether these data suggest that control of Hcy metabolism could be a novel mechanism to prevent age-related 
hearing loss and that the circulating levels of homocysteine could be a novel prognostic factor for hearing 
dysfunction. 
FOLATE DEFICIENT MICE SHOW OXIDATIVE IMBALANCE IN THE COCHLEA 
(A) Schematic representation of 
the role of NADPH oxidases, 
MnSOD and 3-Nitrotyrosine 
during oxidative stress.  
(B) MnSOD, NOX4 and p22phox 
protein levels measured by 
Western blot using β-actin as 
loading control.  
(C) Immunoperoxidase detection 
of 3-NT in the stria vascularis 
(a,c) and cochlear ganglion (b, d) 
of NF (a,b) and FD mice (c, d). 
Intensity level (256 grey scale) of 
the 3-NT expression relative to 
NF mice (e). Data from at least 3 
different experiments involving 
at least 3 mice per condition are 
shown.  
(D) GPX4 and Catalase 
expression levels in the cochlea 
for both groups. Values are 
presented as mean ± SEM. 
Statistical significance: (a)*p<0, 
05; (b) ** p<0,01: (c) *** p<0.001.   
HOMOCYSTEINE  METABOLISM 
FOLATE DEFICIENT MICE SHOW ALTERED HOMOCYSTEINE 
METABOLISM: Changes in systemic levels of metabolites and 
cochlear expression of enzymes   
Scheme showing the folate cycle and 
Hcy metabolism. Arrows indicate the 
changes after folate deprivation.  
SAHH,S-adenosylhomocysteine 
hydrolase; MTR,methionine synthase; 
BHMT,betainehomocysteine 
methyltransferase;ADA,Adenosine 
deaminase;CBS,cystathionine beta 
synthase;ADK, AdenosineKinase;THF, 
Tetrahydrofolate;5-CH3-THF,5-
Methyltetrahydrofolate; 5,10-CH2-
THF,5,10-Methylene Tetrahydrofolate. 
Vitamin B6(cofactor) is shown in green. 
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FOLATE DEFICIENT MICE SHOW ALTERED COCHLEAR MORPHOLOGY:  
Neural & sensory cell loss 
(A) Folate (µg/l), B6 (µg/l) and 
Hcy (µmol/l) plasma levels. (B) 
Expression levels of ADA, 
ADK, CBS, BHMT, MTR and 
SAHH mRNAs measured by 
real-time RT-PCR using 18S as 
the endogenous housekeeping 
control gene. Fold changes 
were calculated using the 
method of Pfaffl (11) and 
experimental efficiencies. 
White bars stand for NF mice 
whilst black bars represent FD 
mice (C) CBS, BHMT, and 
SAHH protein levels measured 
by Western blot using -tubulin 
as loading control. Values are 
presented as mean ± SEM of at 
least six mice per condition. 
Statistical significance: *p<0.05; 
** p<0.01; *** p<0.001. 
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 (A) ABR thresholds in response to click and tone burst stimuli in NF (), and FD () mice after 8 
weeks of diet. (B) The Table shows the click ABR peak and interpeak latencies from NF and FD 
mice. Data are shown as mean ± SEM. Statistical significance: (a) **p<0,01; (b)*** p<0.001. 
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